PHR 957 Block 3 Mentimeter
Exam Study Set
Treatment options for Stage II high risk (T4 lesion) colorectal cancer - ANSWER 1. 5FU +
leucovorin
2. Capecitabine
Would we ever use leucovorin with capecitabine? - ANSWER No
What are the main toxicities of 5FU (bolus vs CI)? - ANSWER Bolus: mucositis,
myelosupression
CI: GI, hand-foot syndrome, cardiotoxicity
What are the main toxicities of capecitabine compared to 5FU? - ANSWER More
hand-foot syndrome, diarrhea
Premeds for 5FU/capecitabine - ANSWER LEC regimen
What is the BBW of capecitabine? - ANSWER DDI with warfarin
Treatment options for Stage III (localized, node +) colorectal cancer - ANSWER 1.
FOLFOX
2. CAPEOX
Major toxicities of FOLFOX regimen - ANSWER Sensory neuropathy, neutropenia
Premeds for FOLFOX regimen - ANSWER MEC regimen
Major toxicities of CAPEOX regimen - ANSWER Diarrhea, hand-foot syndrome,
neuropathy
Premeds for CAPEOX regimen - ANSWER MEC regimen
When would you add an EGFR inhibitor to a colorectal cancer regimen? - ANSWER
Metastatic stage IV wild-type RAS and BRAF tumors (no mutations) AND left-sided tumor
What are the EGFR inhibitors? - ANSWER Cetuximab
Panitumumab
Major toxicities of EGFR inhibitors - ANSWER Skin rash, infusion reaction, low
magnesium
, Premeds for EGFR inhibitors - ANSWER Antihistamine, tetracycline, LEC regimen
What tetracycline should you premedicate with if you are using Cetuximab? - ANSWER
Minocycline
What tetracycline should you premedicate with if you are using Panitumumab? -
ANSWER Doxycycline
First-line treatment options for left-sided KRAS WT, BRAF WT, pMMR colorectal cancer -
ANSWER 1. FOLFOX + EGFRi
2. CAPEOX + EGFRi
3. FOLFIRI + EGFRi
Major toxicities of FOLFIRI regimen - ANSWER Diarrhea, mucositis, neutropenia
Premeds for FOLFIRI regimen - ANSWER Atropine, MEC regimen
When would you add a VEGF inhibitor to a colorectal cancer regimen? - ANSWER
Metastatic stage IV KRAS, NRAS, BRAF mutation OR right-sided tumor
What are the VEGF inhibitors? - ANSWER Bevacizumab
Ramucirumab
First-line treatment options for left-sided KRAS or BRAF mutated, pMMR colorectal
cancer - ANSWER 1. FOLFOX + VEGFi
2. CAPEOX + VEGFi
3. FOLFIRI + VEGFi
First-line treatment options for left-sided dMMR/MSI/H colorectal cancer - ANSWER 1.
FOLFOX + immunotherapy
2. CAPEOX + immunotherapy
3. FOLFIRI + immunotherapy
What are the immunotherapies for colorectal cancer? - ANSWER Pembrolizumab
Nivolumab
Ipilimumab
First-line treatment options for right-sided KRAS WT, BRAF WT, pMMR colorectal
cancer - ANSWER 1. FOLFOX + VEGFi
2. CAPEOX + VEGFi
3. FOLFIRI + VEGFi
Exam Study Set
Treatment options for Stage II high risk (T4 lesion) colorectal cancer - ANSWER 1. 5FU +
leucovorin
2. Capecitabine
Would we ever use leucovorin with capecitabine? - ANSWER No
What are the main toxicities of 5FU (bolus vs CI)? - ANSWER Bolus: mucositis,
myelosupression
CI: GI, hand-foot syndrome, cardiotoxicity
What are the main toxicities of capecitabine compared to 5FU? - ANSWER More
hand-foot syndrome, diarrhea
Premeds for 5FU/capecitabine - ANSWER LEC regimen
What is the BBW of capecitabine? - ANSWER DDI with warfarin
Treatment options for Stage III (localized, node +) colorectal cancer - ANSWER 1.
FOLFOX
2. CAPEOX
Major toxicities of FOLFOX regimen - ANSWER Sensory neuropathy, neutropenia
Premeds for FOLFOX regimen - ANSWER MEC regimen
Major toxicities of CAPEOX regimen - ANSWER Diarrhea, hand-foot syndrome,
neuropathy
Premeds for CAPEOX regimen - ANSWER MEC regimen
When would you add an EGFR inhibitor to a colorectal cancer regimen? - ANSWER
Metastatic stage IV wild-type RAS and BRAF tumors (no mutations) AND left-sided tumor
What are the EGFR inhibitors? - ANSWER Cetuximab
Panitumumab
Major toxicities of EGFR inhibitors - ANSWER Skin rash, infusion reaction, low
magnesium
, Premeds for EGFR inhibitors - ANSWER Antihistamine, tetracycline, LEC regimen
What tetracycline should you premedicate with if you are using Cetuximab? - ANSWER
Minocycline
What tetracycline should you premedicate with if you are using Panitumumab? -
ANSWER Doxycycline
First-line treatment options for left-sided KRAS WT, BRAF WT, pMMR colorectal cancer -
ANSWER 1. FOLFOX + EGFRi
2. CAPEOX + EGFRi
3. FOLFIRI + EGFRi
Major toxicities of FOLFIRI regimen - ANSWER Diarrhea, mucositis, neutropenia
Premeds for FOLFIRI regimen - ANSWER Atropine, MEC regimen
When would you add a VEGF inhibitor to a colorectal cancer regimen? - ANSWER
Metastatic stage IV KRAS, NRAS, BRAF mutation OR right-sided tumor
What are the VEGF inhibitors? - ANSWER Bevacizumab
Ramucirumab
First-line treatment options for left-sided KRAS or BRAF mutated, pMMR colorectal
cancer - ANSWER 1. FOLFOX + VEGFi
2. CAPEOX + VEGFi
3. FOLFIRI + VEGFi
First-line treatment options for left-sided dMMR/MSI/H colorectal cancer - ANSWER 1.
FOLFOX + immunotherapy
2. CAPEOX + immunotherapy
3. FOLFIRI + immunotherapy
What are the immunotherapies for colorectal cancer? - ANSWER Pembrolizumab
Nivolumab
Ipilimumab
First-line treatment options for right-sided KRAS WT, BRAF WT, pMMR colorectal
cancer - ANSWER 1. FOLFOX + VEGFi
2. CAPEOX + VEGFi
3. FOLFIRI + VEGFi